⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14914148 | 1.00 | — | — | |
| SCHEMBL9816014 | 0.96 | — | — | |
| Dimethylamine SCHEMBL25180566 | 0.87 | — | — | |
| SCHEMBL9512592 | 0.84 | — | — | |
| SCHEMBL14331814 | 0.69 | — | — | |
| SCHEMBL2809033 | 0.67 | — | — | |
| SCHEMBL16986050 | 0.65 | — | — | |
| SCHEMBL8665236 | 0.61 | — | — | |
| SCHEMBL5899117 | 0.61 | — | — | |
| SCHEMBL22274936 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4717691-A1 | USE OF BMPR1B INHIBITOR IN INDUCED DEVELOPMENT, AND INDUCTION CULTURE MEDIUM | Iregene Therapeutics Co., Ltd (CN) | 2026-04-01 | — | — | EP | claimed |
| CN-120192677-A | Transparent UV ink composition suitable for inkjet 3D printing and preparation method thereof | 金华造物新材料有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-120025248-A | Energy-saving method and system for removing ethyl acetate by differential pressure thermal coupling method | 中国石油化工股份有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-120003853-A | High-air-permeability PNK deoxidizer packaging material and production process thereof | 嘉兴星越包装材料有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-116573987-B | Method for preparing 1, 3-dihydroxypropane | 中国科学院宁波材料技术与工程研究所 | 2025-04-11 | — | — | CN | claimed |
| CN-119433757-A | Stain-resistant automobile interior material and preparation method thereof | 广东广海大实业有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-119161762-A | Water-soluble supporting material suitable for inkjet 3D printing and preparation method and application thereof | 金华造物新材料有限公司 | 2024-12-20 | — | — | CN | claimed |
| CN-119161773-A | OC transparent composition for CF substrate with low hygroscopicity and low dielectric constant | 江苏博砚电子科技股份有限公司 | 2024-12-20 | — | — | CN | claimed |
| WO-2024239187-A1 | USE OF BMPR1B INHIBITOR IN INDUCED DEVELOPMENT, AND INDUCTION CULTURE MEDIUM | 睿健医药科技(苏州)有限公司 | 2024-11-28 | — | — | WO | claimed |
| CN-118995607-A | Application of BMPR1B inhibitor in induced development and induced culture medium | 睿健医药科技(苏州)有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-117024006-A | Impregnating compound for glass fibers and preparation method, product and application thereof | 巨石集团有限公司 | 2023-11-10 | — | — | CN | claimed |
| EP-4230730-A1 | CHEMICAL CULTURE SYSTEM AND USE THEREOF | Iregene Therapeutics Ltd (CN) | 2023-08-23 | — | — | EP | claimed |
| CN-116573987-A | Method for preparing 1, 3-dihydroxypropane | 中国科学院宁波材料技术与工程研究所 | 2023-08-11 | — | — | CN | claimed |
| CN-114890890-A | Process for recovering methacrylic acid or/and ester residual liquid thereof by catalytic cracking coupled rectification | 中建安装集团有限公司 | 2022-08-12 | — | — | CN | claimed |
| CN-112980792-B | Chemical culture system and application thereof | 武汉睿健医药科技有限公司 | 2022-06-21 | — | — | CN | claimed |
| WO-2022077784-A1 | CHEMICAL CULTURE SYSTEM AND USE THEREOF | 武汉睿健医药科技有限公司 | 2022-04-21 | — | — | WO | claimed |
| CN-111777925-B | HAA system extinction powder coating | 安徽省华安进出口有限公司 | 2022-02-18 | — | — | CN | claimed |
| EP-1730131-B1 | GLUCOPYRANOSYL-SUBSTITUTED BENZOL DERIVATIVES, DRUGS CONTAINING SAID COMPOUNDS, THE USE THEREOF AND METHOD FOR THE PRODUCTION THEREOF | BOEHRINGER INGELHEIM INT (DE) | 2012-05-09 | — | — | EP | claimed |
| EP-2155202-A2 | 3,6-DISUBSTITUTED-IMIDAZO[1,2-B]PYRIDAZINES AND 3,5-DISUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINES AS PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS | Novartis Ag (CH) | 2010-02-24 | — | — | EP | claimed |
| WO-2008138889-A2 | 3, 6-DISUBSTITUTED-IMIDAZO [1, 2-B] PYRIDAZINES AND 3, 5-DISUBSTITUTED PYRAZOLO[1, 5-A] PYRIMIDINES AS PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS | NOVARTIS AG (CH) | 2008-11-20 | — | — | WO | claimed |